DBV Technologies SA (DBV)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
€3.21
Buy
€3.25
€-0.23 (-6.67%)
Prices updated at 12 Dec 2025, 16:35 CET
| Prices minimum 15 mins delay
Prices in EUR
DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.
-0.53%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
No data available
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | 36.63 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | 28.03 |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | 16,824.83 |
| 2015 | 5,605.04 |
Price/Forward earnings (YTD)
-3.43
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -91.63 |
| 2023 | -33.87 |
| 2022 | -48.96 |
| 2021 | -46.69 |
| 2020 | -58.66 |
| 2019 | -73.48 |
| 2018 | -92.72 |
| 2017 | -68.72 |
| 2016 | -35.55 |
| 2015 | -18.51 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 2.40 |
| 2023 | 1.31 |
| 2022 | 1.27 |
| 2021 | 1.48 |
| 2020 | 1.32 |
| 2019 | 1.41 |
| 2018 | 1.42 |
| 2017 | 1.37 |
| 2016 | 1.18 |
| 2015 | 1.07 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
